• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·LBRX.US
Share

LB Pharmaceuticals Stocks

¤ 0Last Updated 18.08.2026

Issuer Rating

Performance

Risk

Recommendation

Sell

¤ 0
Key Takeaways

Risk factor

Profitability factor

Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

11.09.2025 15:00

Shares of schizophrenia drugmaker LB Pharmaceuticals debut on Nasdaq

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

09.10.2026 20:30

30,000 bottles of wine worth €5 million were stolen from a well-known Italian winery

09.10.2026 20:01

"The Toll Collector on the Consumer AI Highway": Ives Highlights Apple's Advantage in the Race

09.10.2026 19:00

Shares of luxury brands have fallen 25% this year. When can we expect a turnaround, and which ones should we bet on?

09.10.2026 18:49

U.S. stocks rebounded after two days of declines: Is the AI rally continuing?

09.10.2026 17:48

Data center optics are sold out for the next two years — Lumentum. Who else is seeing gains?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026